The National Alliance for Pharmacy Education (NAPE) is pleased to partner with the Society of Hospital Pharmacists of Australia to offer a pathway to MMR accreditation for recent graduates of approved NAPE Master’s programs.
Process for applying for NAPE MMR credential
Recent graduates (within 5 years of course completion) of approved NAPE Master’s programs will apply to NAPE by submitting a portfolio of evidence.
The evidence submitted must include the following, many components of which are already undertaken and assessed within NAPE Master’s programs:
Completed application form
Submitted with all details below firstname.lastname@example.org
Completion of an approved NAPE Master’s program within the last 5 years
Certified copy of transcript.
Completion of at least one shpaclinCAT (or equivalent) within the preceding 12 months
Must be undertaken in a setting involving medicines management of patients with risk factors known to predispose them to medication related adverse events (as defined in the SHPA Fact Sheet: Accreditation System for Medication Management Reviews).*
*Preferably carried out by a trained clinCAT evaluator. Candidates without access to a trained clinCAT evaluator should contact NAPE to investigate access to one via a NAPE university.
Certified copy of clinCAT.
clinCAT evaluator’s name to appear on theSHPA website, or submission of certified copy of evidence that evaluator is clinCAT trained
Current registration as a pharmacist
AHPRA registration number
Current practice in medicines management over the last 2 years
Medicines management is defined by the medication management cycle in the APAC Guiding principles to achieve continuity in medication management 2005.
Continuing Professional Development (CPD)
Minimum 60CPD credits in most recent complete year, of which no more than 10 credits are Group-1 (consistent with requirement for SHPA accreditation).
Preference is for at least 12 credits related to medicines management of patients with risk factors known to predispose them to medication related adverse events (as defined in the SHPA Fact Sheet: Accreditation System for Medication Management Reviews).
One full (previous) year CPD record plus current year to date summary record (more information may be requested)
Medicines management records
Documented medicines management of 8 patients, over the preceding 12 months, with risk factors known to predispose them to medication related adverse events (as defined in the SHPA Fact Sheet: Accreditation System for Medication Management Reviews).
These should demonstrate skills such as priority setting, problem solving, communication, interventions & outcomes, monitoring and follow up.
Copies of documentation signed by a senior staff member or attending clinician (eg GP)
Applications, including the application form and all evidence, should be submitted to email@example.com
Once approved, applicants will be invited to attend an Objective Structured Clinical Examination (OSCE) to demonstrate skills in the process of medication management of complex general medical patients. OSCEs will be offered annually; additional examinations may be offered if there is demand. There will be a fee to undertake the OSCE (to be determined). Recognition of prior learning may be applied for if an OSCE of appropriate content and assessment has been completed as part of the Master’s degree.
Successful applicants will be issued with a “NAPE Certificate of Currency for MMR accreditation” which is recognized by SHPA as a core component of MMR accreditation. SHPA remains the accrediting body and will issue certificates according to current processes. Standard fees are payable to SHPA in addition to the NAPE fee for assessing the candidate and providing the certificate of currency.
Recredentialing will be required every 5 years (see below).
Approved NAPE Master’s programs
The approved courses are:
- Monash University Master of Clinical Pharmacy
- Monash University Master of Pharmacy Practice (some units are compulsory for MMR accreditation; see link to more details below)
- The University of Queensland Master of Clinical Pharmacy
- University of South Australia Master of Clinical Pharmacy
Download further details of the NAPE programs approved for this pathway.
Recredentialling will be required every 5 years. The process will be similar to that required for initial credentialing (submission of portfolio of evidence, OSCE)